Cytura Therapeutics
Latest round
- Seed
Last raised
- Apr 2019
Total raised
- Undisclosed
Investors
- 3
About Cytura Therapeutics
Founded in 2018 by Ad Van Gorp, Cytura Therapeutics BV operates in the Netherlands, specifically focusing on innovative cancer therapies.U.Cytura Therapeutics specializes in the development of innovative therapies aimed at addressing genomic instability, a critical issue in cancer progression and treatment resistance. Their core offerings focus on targeting this instability through both standalone and combination therapies, designed to prevent therapy resistance and reduce the likelihood of cancer relapse. These products intend to improve the effectiveness of cancer treatments while enhancing the quality of life for patients globally.Cytura Therapeutics generates revenue through partnerships with healthcare organizations and pharmaceutical firms, integrating their therapies into existing cancer treatment protocols. The company’s revenue model involves B2B transactions, collaborating with hospitals and research institutions to facilitate the adoption of their genomic instability-targeted therapies.Cytura Therapeutics plans to enhance its product offerings by designing new therapies targeting genomic instability, with specific timelines for these launches yet to be disclosed. The company aims to expand into new markets, particularly in North America and Europe, to increase its global reach.
Who invested in Cytura Therapeutics
3 investors across 1 round
See all investors in Cytura Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Apr 23, 2019
Amount
Undisclosed
Investors
Questions about Cytura Therapeutics
Who invested in Cytura Therapeutics?
Cytura Therapeutics has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cytura Therapeutics raised?
Cytura Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Cytura Therapeutics last raise money?
Cytura Therapeutics's most recent round on record is a Seed, in Apr 2019.
What does Cytura Therapeutics do?
Founded in 2018 by Ad Van Gorp, Cytura Therapeutics BV operates in the Netherlands, specifically focusing on innovative cancer therapies.
Where is Cytura Therapeutics headquartered?
Cytura Therapeutics is headquartered in Netherlands.
Which VCs invest in companies like Cytura Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Cytura Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Cytura Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.